Építés alatt – nem éles oldal
Belépés

What researchers published on Huntington-kór

5998 papers, newest first.

Showing 60 of 5998

  • Expression of Concern for SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington's disease models.The Journal of clinical investigation
  • Computer vision-aided locomotor behavioral analysis identifies therapeutic motor signatures in a mouse model of Huntington's disease.Pharmacological research
  • Psychometric validation of the Spanish version of the Huntington's Disease Health-Related Quality of Life Questionnaire (HDQoL©).Clinical neurology and neurosurgery
  • Repairing the disruption of protein homeostasis ameliorates REM sleep dysfunction in mouse models of Huntington's disease.Sleep
  • ÁttekintésPharmacological strategies to manage oxidative stress in Huntington's disease: from preclinical models to clinical trials.Frontiers in pharmacology
  • Superpixel-ComBat multi-site harmonization of unpaired T1W MRI data in Huntington's disease.Neuroimage. Reports
  • Interoception predicts empathy, social anxiety and quality of life in Huntington's disease.Journal of neurology
  • Sustained Improvements in Chorea Associated with Huntington Disease with Once-Daily Valbenazine: Interim Results from a Long-Term Open-Label Study.CNS spectrums
  • ÁttekintésMiro1 and mitochondrial dysfunction in Huntington's disease: Emerging mechanistic links and therapeutic perspectives.Mitochondrion
  • Qualitative insights from partners of individuals with Huntington's disease: the quality of life of an under-researched population.Orphanet journal of rare diseases
  • Primer site variations resulting in false-negative Huntington's disease testing.Journal of medical genetics
  • Isozyme-Specific Inhibition of GSK-3 Reveals Distinct Cellular Responses in Huntington's Disease Fibroblasts.Journal of neurochemistry
  • The SorCS2-derived macrocycle TT-P34 drives neuroprotection in animal models of neurodegeneration.Acta neuropathologica communications
  • ÁttekintésThe hepatic secretome-microglia axis in huntington's disease: Linking peripheral metabolic dysfunction to neuroinflammation and novel therapeutic opportunities.Metabolic brain disease
  • In vivo assessment of brain microstructure in patients with Huntington's disease using quantitative MRI.Journal of neurology
  • NeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington's disease.Molecular therapy : the journal of the American Society of Gene Therapy
  • Forecasting and Dynamics of Huntington's disease: A Machine Learning approach for Fractional-Order Mathematical Model.Journal of advanced research
  • The Treatment of Psychiatric Symptoms in Huntington's Disease: A Systematic Review.Current neuropharmacology
  • Rhes as a Potential Modulator of PINK1/Parkin-Dependent Mitophagy in Huntington's Disease.Journal of integrative neuroscience
  • The postsynaptic scaffolding protein SAPAP3 shapes mitochondrial activity: the case of Huntington's disease.Cell death & disease
  • Cell-specific transcription dysregulation in human Huntington's disease-positive developing striatum.Brain : a journal of neurology
  • Bioinformatics Analysis to Reveal Potential Targets of Huntington's Disease.IET systems biology
  • CSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern.Neurology(R) neuroimmunology & neuroinflammation
  • Computational modeling and preclinical evaluation support targeting somatic instability for Huntington's disease treatment.Nature communications
  • Somatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington's disease cortical and striatal neurons.Cell
  • Multimodal spatial transcriptomics redefines cortical pathology in Huntington's disease.Cell
  • ÁttekintésNeuroprotective roles of Klotho signaling in Huntington's disease: From molecular insights to clinical translation.IBRO neuroscience reports
  • Early Administration of Methylene Blue Attenuates Mitochondrial Dysfunction and Cognitive Deficits in a Model of Huntington's Disease.Biology
  • Should Huntington's Disease Remains the First Genetic Consideration in Adults Presenting with Combined Chorea and Ataxia in Resource-Limited Settings?Movement disorders clinical practice
  • Quantifying multidisciplinary collaboration in Huntington's disease before and after service redesign: a social network analysis.BMC health services research
  • HD-DRUM Rhythmic Training in Huntington's Disease: Feasibility, Motor, and Brain Microstructural Pilot Signals.Movement disorders clinical practice
  • PreprintCerebrospinal Fluid Myeloperoxidase Is Associated With Putamen Volume Beyond Neurofilament Light in Huntington's Disease.medRxiv : the preprint server for health sciences
  • Randomizált vizsgálatAntidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF-HD Placebo-Controlled Trial.Neurology
  • Healthcare trajectories diverge years before Huntington disease is recorded in claims: a nationwide French matched cohort study.Journal of neurology, neurosurgery, and psychiatry
  • Emotion regulation difficulties are selectively associated with executive and behavioural apathy in Huntington's disease.Journal of neurology
  • Beyond Clinical Outcomes: What Antidopaminergic Medications Teach Us About Causal Inference in Huntington Disease.Neurology
  • Progenitor transcriptional alterations link fetal and adult pathology in Huntington's disease.Brain : a journal of neurology
  • ÁttekintésBeyond inherited repeat length: somatic expansions in Huntington disease.Current opinion in genetics & development
  • Cas9 nickase-mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington's disease mouse model.Science translational medicine
  • ÁttekintésThe potential of AI inspired approaches for patient monitoring in drug development for Huntington's disease: capturing the digital exhaust for activities of daily living.Frontiers in molecular medicine
  • Autonomic dysfunction in patients with Huntington's disease: Evidence from standardized cardiovascular reflex testing.Journal of Huntington's disease
  • Huntington's disease clinical trials update: August 2026.Journal of Huntington's disease
  • ÁttekintésNeuroprotective Role of Withaferin A in Huntington's Disease: Current Evidence and Future Perspectives.Molecular neurobiology
  • The Power of Two: Combined MSH3/HTT Silencing in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
  • iPSC neurodegenerative disease initiative isogenic CAG repeat iPSC line for Huntington's disease.Journal of Huntington's disease
  • Attentional emotional bias in Huntington's disease: The "Hyper-Positive" effect.Cognitive, affective & behavioral neuroscience
  • Neurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross-Sectional Multimodal Analysis.Movement disorders : official journal of the Movement Disorder Society
  • Recent Advances in Pharmacological Interventions for Huntington's Disease: Evidence from Clinical Translation.Reviews on recent clinical trials
  • Huntington's disease vasculopathy is barrier-type-selective and arteriolar-dominant with spatially-coupled astrogliosis and reversible by S1pr1 stimulation.Nature communications
  • Unmasking Huntington Disease: How a Neuropsychiatric Crisis Overcame Cultural Barriers to a Delayed Diagnosis.Clinical case reports
  • Role of Miro1 in Mitochondrial Dysfunction and Neurodegeneration in Huntington's Disease.Current neurovascular research
  • EsetismertetésJuvenile Huntington Disease With Cerebellar-Predominant Atrophy Identified by Genome Sequencing.Annals of clinical and translational neurology
  • Striatal astrocyte μ-crystallin (Crym) loss contributes to early-stage Huntington's disease pathophysiology.Neuron
  • Plasma Lipid Remodeling across Preclinical Burden, Disease Onset, and Early Motor Severity in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
  • PreprintEffect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD.medRxiv : the preprint server for health sciences
  • Safety and efficacy of SOM3355 in patients with Huntington's disease (SOMCT03): a phase 2b, randomised, placebo-controlled, multicentre, dose-ranging study.EClinicalMedicine
  • PreprintDepletion of border-associated macrophages impairs CSF flow and exacerbates extranuclear mutant Huntingtin aggregation in the zQ175DN mouse model of Huntington's disease.bioRxiv : the preprint server for biology
  • Pellagra encephalopathy in Huntington disease: An autopsy case.Journal of neuropathology and experimental neurology
  • Joint Analysis for Multivariate Longitudinal and Event Time Data With a Change Point Anchored at Interval-Censored Event Time.Statistics in medicine
  • Staging disease without illness: ethical issues of the Huntington's Disease Integrated Staging System (HD-ISS).Journal of medical ethics